| scholarly article | Q13442814 |
| P50 | author | Clay F. Semenkovich | Q42738655 |
| Jenny Ting | Q50858300 | ||
| Seungmin Hwang | Q55293404 | ||
| Babak Razani | Q56835760 | ||
| Haitao Wen | Q89457548 | ||
| Trey Coleman | Q114301141 | ||
| Herbert W. Virgin | Q28407524 | ||
| P2093 | author name string | Michael B Kastan | |
| Chu Feng | |||
| Roy Emanuel | |||
| P2860 | cites work | Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes | Q23757358 |
| Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice | Q24303752 | ||
| Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor | Q24569647 | ||
| Autophagy in immunity and inflammation | Q24595707 | ||
| Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene | Q24617547 | ||
| Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice | Q24623151 | ||
| Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization | Q24631966 | ||
| Oxidation of free amino acids and amino acid residues in proteins by radiolysis and by metal-catalyzed reactions | Q40835305 | ||
| Cholesterol and oxysterol metabolism and subcellular distribution in macrophage foam cells. Accumulation of oxidized esters in lysosomes | Q40899444 | ||
| Low-dose oral sirolimus reduces atherogenesis, vascular inflammation and modulates plaque composition in mice lacking the LDL receptor | Q41424778 | ||
| Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities | Q43678714 | ||
| Dietary restriction reduces atherosclerosis and oxidative stress in the aorta of apolipoprotein E-deficient mice | Q44014870 | ||
| Rapamycin attenuates atherosclerosis induced by dietary cholesterol in apolipoprotein-deficient mice through a p27 Kip1 -independent pathway | Q44716927 | ||
| 7-ketocholesterol induces protein ubiquitination, myelin figure formation, and light chain 3 processing in vascular smooth muscle cells | Q45086352 | ||
| Aggregated LDL and lipid dispersions induce lysosomal cholesteryl ester accumulation in macrophage foam cells | Q46604874 | ||
| "New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis | Q46626411 | ||
| Rapamycin attenuates atherosclerotic plaque progression in apolipoprotein E knockout mice: inhibitory effect on monocyte chemotaxis | Q46701396 | ||
| Prevention of atherosclerosis by the mTOR inhibitor everolimus in LDLR-/- mice despite severe hypercholesterolemia | Q46916538 | ||
| Effects of heterozygous lipoprotein lipase deficiency on diet-induced atherosclerosis in mice | Q47920076 | ||
| Critical role of apoptotic speck protein containing a caspase recruitment domain (ASC) and NLRP3 in causing necrosis and ASC speck formation induced by Porphyromonas gingivalis in human cells | Q51833225 | ||
| How shall I eat thee? | Q51983235 | ||
| Skeletal muscle respiratory uncoupling prevents diet-induced obesity and insulin resistance in mice | Q54034693 | ||
| Cholesterol delivered to macrophages by oxidized low density lipoprotein is sequestered in lysosomes and fails to efflux normally | Q54034996 | ||
| The intracellular storage and turnover of apolipoprotein B of oxidized LDL in macrophages | Q54268090 | ||
| Oxidized low density lipoprotein is resistant to cathepsins and accumulates within macrophages | Q54290578 | ||
| The Inflammasome in Atherosclerosis and Type 2 Diabetes | Q62818661 | ||
| Cholesterol crystal formation and growth in model bile solutions | Q71073142 | ||
| Cell composition, replication, and apoptosis in atherosclerotic plaques after 6 months of cholesterol withdrawal | Q77167596 | ||
| Autophagy suppresses tumorigenesis through elimination of p62 | Q24650670 | ||
| Autophagy in the Pathogenesis of Disease | Q27860558 | ||
| Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice | Q28131756 | ||
| A role for mitochondria in NLRP3 inflammasome activation | Q28131794 | ||
| Loss of autophagy in the central nervous system causes neurodegeneration in mice | Q28131804 | ||
| Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf | Q28266417 | ||
| The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress | Q28506886 | ||
| Autophagy in the heart and liver during normal aging and calorie restriction | Q28582989 | ||
| Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice | Q28588080 | ||
| Autophagy-based unconventional secretory pathway for extracellular delivery of IL-1β | Q29030555 | ||
| p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death | Q29547297 | ||
| Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome | Q29547419 | ||
| The role of autophagy during the early neonatal starvation period | Q29547489 | ||
| Autophagy as a regulated pathway of cellular degradation | Q29547914 | ||
| Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production | Q29614472 | ||
| Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1 | Q29614473 | ||
| NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals | Q29615704 | ||
| Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling | Q29616024 | ||
| The Inflammasome NLRs in Immunity, Inflammation, and Associated Diseases | Q29616025 | ||
| Self-eating and self-killing: crosstalk between autophagy and apoptosis | Q29617748 | ||
| Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation | Q33644572 | ||
| Macrophage fatty-acid synthase deficiency decreases diet-induced atherosclerosis | Q34004031 | ||
| Autophagy: basic principles and relevance to disease | Q34585381 | ||
| Autophagy Controls IL-1β Secretion by Targeting Pro-IL-1β for Degradation | Q34684708 | ||
| Small nucleolar RNAs U32a, U33, and U35a are critical mediators of metabolic stress | Q35111712 | ||
| Fatty acid synthase modulates homeostatic responses to myocardial stress. | Q35183031 | ||
| Cardiac autophagy is a maladaptive response to hemodynamic stress | Q35839989 | ||
| Sequestration of acetylated LDL and cholesterol crystals by human monocyte-derived macrophages | Q36235266 | ||
| Advanced atherosclerotic foam cell formation has features of an acquired lysosomal storage disorder | Q36481021 | ||
| Autophagy in atherosclerosis: a cell survival and death phenomenon with therapeutic potential | Q37391884 | ||
| The NLRP3 inflammasome: a sensor for metabolic danger? | Q37675505 | ||
| Mitochondrial reactive oxygen species drive proinflammatory cytokine production | Q37847792 | ||
| The inflammasome: an integrated view | Q37925072 | ||
| Computed tomographic assessment of atherosclerosis in ancient Egyptian mummies | Q38869586 | ||
| Autophagy regulates cholesterol efflux from macrophage foam cells via lysosomal acid lipase | Q40374390 | ||
| Lysosomal cholesterol derived from mildly oxidized low density lipoprotein is resistant to efflux | Q40820350 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 4 | |
| P921 | main subject | atherosclerosis | Q12252367 |
| autophagy | Q288322 | ||
| inflammasome complex | Q412405 | ||
| P304 | page(s) | 534-544 | |
| P577 | publication date | 2012-03-20 | |
| P1433 | published in | Cell Metabolism | Q1254684 |
| P1476 | title | Autophagy links inflammasomes to atherosclerotic progression | |
| P478 | volume | 15 |
| Q90107491 | A role for autophagy in carotid atherosclerosis |
| Q50220296 | Activating cannabinoid receptor 2 alleviates pathogenesis of experimental autoimmune encephalomyelitis via activation of autophagy and inhibiting NLRP3 inflammasome |
| Q57821309 | Activation of CD137 Signaling Enhances Vascular Calcification through c-Jun N-Terminal Kinase-Dependent Disruption of Autophagic Flux |
| Q33862296 | Adipose tissue macrophages in the development of obesity-induced inflammation, insulin resistance and type 2 Diabetes |
| Q37066948 | Age-associated vascular inflammation promotes monocytosis during atherogenesis. |
| Q40309248 | Atg7 Deficiency Intensifies Inflammasome Activation and Pyroptosis in Pseudomonas Sepsis |
| Q93012793 | Atherothrombosis and the NLRP3 inflammasome - endogenous mechanisms of inhibition |
| Q38644108 | Atorvastatin ameliorates LPS-induced inflammatory response by autophagy via AKT/mTOR signaling pathway. |
| Q49687928 | Autophagy Dysregulation and Obesity-Associated Pathologies. |
| Q36725800 | Autophagy Is Dispensable for Macrophage-Mediated Lipid Homeostasis in Adipose Tissue |
| Q92717652 | Autophagy and Age-Related Eye Diseases |
| Q38065286 | Autophagy and Intestinal Homeostasis |
| Q37729235 | Autophagy and Microglia: Novel Partners in Neurodegeneration and Aging. |
| Q38588827 | Autophagy and autophagy-related proteins in the immune system |
| Q34545125 | Autophagy and cardiometabolic risk factors |
| Q38074032 | Autophagy and inflammatory diseases |
| Q91906834 | Autophagy and its regulation by ginseng components |
| Q34506174 | Autophagy and oxidative stress in cardiovascular diseases |
| Q38148473 | Autophagy as a crosstalk mediator of metabolic organs in regulation of energy metabolism |
| Q48255270 | Autophagy balances inflammation in innate immunity |
| Q37141763 | Autophagy deficiency in myeloid cells increases susceptibility to obesity-induced diabetes and experimental colitis |
| Q35498851 | Autophagy facilitates secretion and protects against degeneration of the Harderian gland |
| Q58699659 | Autophagy in Metabolic Age-Related Human Diseases |
| Q26866165 | Autophagy in cardiovascular biology |
| Q47301106 | Autophagy in health and disease: focus on the cardiovascular system |
| Q38094885 | Autophagy in obesity and atherosclerosis: Interrelationships between cholesterol homeostasis, lipoprotein metabolism and autophagy in macrophages and other systems |
| Q52884771 | Autophagy in the cardiovascular system |
| Q37497424 | Autophagy involved in lipopolysaccharide-induced foam cell formation is mediated by adipose differentiation-related protein |
| Q37139931 | Autophagy is associated with cell fate in the process of macrophage-derived foam cells formation and progress |
| Q47605775 | Autophagy is required for endothelial cell alignment and atheroprotection under physiological blood flow |
| Q47285871 | Autophagy limits activation of the inflammasomes. |
| Q38198952 | Autophagy--a key player in cellular and body metabolism |
| Q35484237 | Autophagy: an emerging therapeutic target in vascular diseases |
| Q35194143 | Berberine alleviates ox-LDL induced inflammatory factors by up-regulation of autophagy via AMPK/mTOR signaling pathway. |
| Q37744848 | Berberine-sonodynamic therapy induces autophagy and lipid unloading in macrophage |
| Q92324411 | Broken heart: A matter of the endoplasmic reticulum stress bad management? |
| Q89444152 | C1q/TNF-Related Protein 9 Inhibits THP-1 Macrophage Foam Cell Formation by Enhancing Autophagy |
| Q26858902 | Cardiovascular Autophagy: Crossroads of Pathology, Pharmacology and Toxicology |
| Q38130112 | Cardiovascular autophagy: concepts, controversies, and perspectives |
| Q53431559 | Cellular repressor of E1A-stimulated genes inhibits inflammation to decrease atherosclerosis in ApoE(-/-) mice |
| Q27024737 | Cholesterol Crystals and Inflammation |
| Q52691185 | Cholesterol and bile acid-mediated regulation of autophagy in fatty liver diseases and atherosclerosis |
| Q39047738 | Cholesterol crystallization in human atherosclerosis is triggered in smooth muscle cells during the transition from fatty streak to fibroatheroma |
| Q28086912 | Cholesterol, inflammation and innate immunity |
| Q47658933 | Chronic skin inflammation accelerates macrophage cholesterol crystal formation and atherosclerosis. |
| Q42572715 | Coronary atherosclerosis: Significance of autophagic armour |
| Q112744936 | Cysteamine Decreases Low-Density Lipoprotein Oxidation, Causes Regression of Atherosclerosis, and Improves Liver and Muscle Function in Low-Density Lipoprotein Receptor-Deficient Mice |
| Q38756684 | Cysteine proteases in atherosclerosis |
| Q55381729 | Defective Autophagy in Atherosclerosis: To Die or to Senesce? |
| Q47132046 | Defective Protein Catabolism in Atherosclerotic Vascular Inflammation |
| Q57203155 | Defective autophagy in vascular smooth muscle cells enhances cell death and atherosclerosis |
| Q37265183 | Degradation and beyond: the macrophage lysosome as a nexus for nutrient sensing and processing in atherosclerosis |
| Q43898299 | Delphinidin-3-glucoside protects human umbilical vein endothelial cells against oxidized low-density lipoprotein-induced injury by autophagy upregulation via the AMPK/SIRT1 signaling pathway |
| Q42771466 | Dietary PUFAs attenuate NLRP3 inflammasome activation via enhancing macrophage autophagy. |
| Q33757132 | Disruption of mammalian target of rapamycin complex 1 in macrophages decreases chemokine gene expression and atherosclerosis |
| Q41584412 | Distinct lysosome phenotypes influence inflammatory function in peritoneal and bone marrow-derived macrophages |
| Q27308058 | Disturbed Flow Induces Autophagy, but Impairs Autophagic Flux to Perturb Mitochondrial Homeostasis. |
| Q38066805 | Drug-induced macrophage autophagy in atherosclerosis: for better or worse? |
| Q39134393 | Eating the Dead to Keep Atherosclerosis at Bay. |
| Q40955556 | Effects of peritoneal macrophage autophagy on the immune function of sepsis mice |
| Q26768878 | Emerging evidence for beneficial macrophage functions in atherosclerosis and obesity-induced insulin resistance |
| Q34239967 | Emerging roles of mitochondria ROS in atherosclerotic lesions: causation or association? |
| Q37588538 | Enhancement in efferocytosis of oxidized low-density lipoprotein-induced apoptotic RAW264.7 cells through Sirt1-mediated autophagy |
| Q30855438 | Exploiting macrophage autophagy-lysosomal biogenesis as a therapy for atherosclerosis. |
| Q58606351 | Exploring the Role of Autophagy-Related Gene 5 () Yields Important Insights Into Autophagy in Autoimmune/Autoinflammatory Diseases |
| Q92539109 | Frontline Science: Acyl-CoA synthetase 1 exacerbates lipotoxic inflammasome activation in primary macrophages |
| Q64064553 | Genome-wide association studies for 30 haematological and blood clinical-biochemical traits in Large White pigs reveal genomic regions affecting intermediate phenotypes |
| Q64081880 | Ginkgo Biloba Leaf Extract Attenuates Atherosclerosis in Streptozotocin-Induced Diabetic ApoE-/- Mice by Inhibiting Endoplasmic Reticulum Stress via Restoration of Autophagy through the mTOR Signaling Pathway |
| Q44258998 | Ginsenoside Rb1 Enhances Atherosclerotic Plaque Stability by Improving Autophagy and Lipid Metabolism in Macrophage Foam Cells |
| Q50084771 | Ginsenoside Rg1 inhibits apoptosis by increasing autophagy via the AMPK/mTOR signaling in serum deprivation macrophages |
| Q35034843 | Glucose and palmitate uncouple AMPK from autophagy in human aortic endothelial cells |
| Q90018324 | High-protein diets increase cardiovascular risk by activating macrophage mTOR to suppress mitophagy |
| Q57787015 | Hydrogen attenuated oxidized low-density lipoprotein-induced inflammation through the stimulation of autophagy via sirtuin 1 |
| Q37603446 | Hypericin-mediated sonodynamic therapy induces autophagy and decreases lipids in THP-1 macrophage by promoting ROS-dependent nuclear translocation of TFEB. |
| Q46547305 | Hyperoxia-mediated LC3B activation contributes to the impaired transdifferentiation of type II alveolar epithelial cells (AECIIs) to type I cells (AECIs). |
| Q42961537 | Hypoxia in plaque macrophages: a new danger signal for interleukin-1β activation? |
| Q90698365 | Impaired Autophagy in CD11b+ Dendritic Cells Expands CD4+ Regulatory T Cells and Limits Atherosclerosis in Mice |
| Q26863422 | Implications of autophagy for vascular smooth muscle cell function and plasticity |
| Q37255799 | Inclusion bodies enriched for p62 and polyubiquitinated proteins in macrophages protect against atherosclerosis |
| Q34076245 | Induction of lysosomal biogenesis in atherosclerotic macrophages can rescue lipid-induced lysosomal dysfunction and downstream sequelae |
| Q28389531 | Inflammasomes and metabolic disorders: old genes in modern diseases |
| Q38231099 | Inflammation and cardiovascular disease: from pathogenesis to therapeutic target. |
| Q42018004 | Intact endothelial autophagy is required to maintain vascular lipid homeostasis |
| Q38428350 | Intercellular interplay between Sirt1 signalling and cell metabolism in immune cell biology |
| Q28830062 | Knockdown of GSK3β increases basal autophagy and AMPK signalling in nutrient-laden human aortic endothelial cells |
| Q47895048 | LC3-Associated Phagocytosis and Inflammation. |
| Q36516946 | Lanatoside C Promotes Foam Cell Formation and Atherosclerosis |
| Q93017682 | Long Noncoding Competing Endogenous RNA Networks in Age-Associated Cardiovascular Diseases |
| Q53302687 | Low Shear Stress Inhibited Endothelial Cell Autophagy Through TET2 Downregulation |
| Q64092526 | Low density lipoprotein mimics insulin action on autophagy and glucose uptake in endothelial cells |
| Q52663732 | Lysosomal Cholesterol Hydrolysis Couples Efferocytosis to Anti-Inflammatory Oxysterol Production |
| Q38195943 | Lysosomal cholesterol accumulation: driver on the road to inflammation during atherosclerosis and non-alcoholic steatohepatitis |
| Q34585737 | Lysosome: regulator of lipid degradation pathways |
| Q64076295 | Macrophage Death as a Pharmacological Target in Atherosclerosis |
| Q26780531 | Macrophage Heterogeneity and Plasticity: Impact of Macrophage Biomarkers on Atherosclerosis |
| Q36602809 | Macrophage Phenotype and Function in Different Stages of Atherosclerosis |
| Q36584242 | Macrophage autophagy in atherosclerosis |
| Q41504958 | Macrophage autophagy protects against liver fibrosis in mice |
| Q38644325 | Macrophage metabolism in atherosclerosis |
| Q37355594 | Macrophage specific caspase-1/11 deficiency protects against cholesterol crystallization and hepatic inflammation in hyperlipidemic mice |
| Q26738772 | Macrophages and Their Role in Atherosclerosis: Pathophysiology and Transcriptome Analysis |
| Q34368005 | Macrophages in atherosclerosis: a dynamic balance. |
| Q35595537 | Macrophages in immunopathology of atherosclerosis: a target for diagnostics and therapy. |
| Q98613684 | Metabolic Reprogramming of Macrophages in Atherosclerosis: Is It All about Cholesterol? |
| Q98386080 | Metformin reduces saturated fatty acid-induced lipid accumulation and inflammatory response by restoration of autophagic flux in endothelial cells |
| Q40138320 | MiR-216a: a link between endothelial dysfunction and autophagy |
| Q35200081 | MicroRNA control of high-density lipoprotein metabolism and function |
| Q47829700 | MicroRNA-214-3p: A link between autophagy and endothelial cell dysfunction in atherosclerosis. |
| Q90686994 | Microparticles and autophagy: a new frontier in the understanding of atherosclerosis in rheumatoid arthritis |
| Q92322133 | Miltefosine increases macrophage cholesterol release and inhibits NLRP3-inflammasome assembly and IL-1β release |
| Q36979168 | Mitochondria and endothelial function |
| Q38947693 | Mitochondria and the NLRP3 inflammasome: physiological and pathological relevance. |
| Q46296706 | Mitochondrial Respiration Is Reduced in Atherosclerosis, Promoting Necrotic Core Formation and Reducing Relative Fibrous Cap Thickness |
| Q37301680 | Mitophagy acts as a safeguard mechanism against human vascular smooth muscle cell apoptosis induced by atherogenic lipids. |
| Q90663952 | Mitophagy in Cardiovascular Diseases |
| Q34403101 | Moderate hypoxia potentiates interleukin-1β production in activated human macrophages |
| Q38042543 | Molecular and cellular mechanisms of macrophage survival in atherosclerosis. |
| Q26765189 | Monocyte Activation in Immunopathology: Cellular Test for Development of Diagnostics and Therapy |
| Q37279687 | Moving Beyond JUPITER: Will Inhibiting Inflammation Reduce Vascular Event Rates? |
| Q38753559 | Mst1 participates in the atherosclerosis progression through macrophage autophagy inhibition and macrophage apoptosis enhancement |
| Q92818213 | Novel Genetic Locus of Visceral Fat and Systemic Inflammation |
| Q92652489 | Novel Insights Into the NLRP 3 Inflammasome in Atherosclerosis |
| Q35229446 | ORMDL orosomucoid-like proteins are degraded by free-cholesterol-loading-induced autophagy |
| Q36316945 | ORMDL3 contributes to the risk of atherosclerosis in Chinese Han population and mediates oxidized low-density lipoprotein-induced autophagy in endothelial cells |
| Q37489807 | Oxidative Stress and Autophagy in Cardiovascular Homeostasis |
| Q38928867 | Oxidized low-density lipoprotein inhibits THP-1-derived macrophage autophagy via TET2 down-regulation |
| Q47142239 | Oxidized low-density lipoprotein-induced p62/SQSTM1 accumulation in THP-1-derived macrophages promotes IL-18 secretion and cell death |
| Q57285031 | P2X antagonists inhibit HIV-1 productive infection and inflammatory cytokines IL-10 and IL-1β in a human tonsil explant model |
| Q49459817 | PCSK9 deficiency reduces atherosclerosis, apolipoprotein B secretion, and endothelial dysfunction |
| Q56770252 | PPARγ Deficiency Suppresses the Release of IL-1β and IL-1α in Macrophages via a Type 1 IFN-Dependent Mechanism |
| Q36751795 | Pdcd4 deficiency enhances macrophage lipoautophagy and attenuates foam cell formation and atherosclerosis in mice. |
| Q53738748 | Periodontal bacterial invasion and infection: contribution to atherosclerotic pathology |
| Q38102720 | Periodontal bacterial invasion and infection: contribution to atherosclerotic pathology |
| Q35644649 | Perivascular adipose tissue-derived adiponectin inhibits collar-induced carotid atherosclerosis by promoting macrophage autophagy |
| Q39381435 | Perpetual change: autophagy, the endothelium, and response to vascular injury |
| Q36822328 | Physiological Difference in Autophagic Flux in Macrophages From 2 Mouse Strains Regulates Cholesterol Ester Metabolism |
| Q45981930 | Prdx1 (peroxiredoxin 1) deficiency reduces cholesterol efflux via impaired macrophage lipophagic flux. |
| Q38573436 | Prix Fixe: Efferocytosis as a Four-Course Meal |
| Q36349956 | Protective effect of autophagy on human retinal pigment epithelial cells against lipofuscin fluorophore A2E: implications for age-related macular degeneration |
| Q37032282 | Redox control of inflammation in macrophages |
| Q60946590 | Role of Autophagy in Proteostasis: Friend and Foe in Cardiac Diseases |
| Q39335880 | Role of Endoplasmic Reticulum Stress, Autophagy, and Inflammation in Cardiovascular Disease |
| Q88633708 | Role of Myeloid Lineage Cell Autophagy in Ischemic Brain Injury |
| Q41787404 | Role of NLRP3 Inflammasomes in Atherosclerosis |
| Q28354735 | Role of Uric Acid Metabolism-Related Inflammation in the Pathogenesis of Metabolic Syndrome Components Such as Atherosclerosis and Nonalcoholic Steatohepatitis |
| Q51577334 | SIRT1/Atg5/autophagy are involved in the antiatherosclerosis effects of ursolic acid |
| Q51279703 | SNAPIN is critical for lysosomal acidification and autophagosome maturation in macrophages |
| Q31152970 | Selective inhibition of PI3K/Akt/mTOR signaling pathway regulates autophagy of macrophage and vulnerability of atherosclerotic plaque |
| Q38205605 | Self-eating in the plaque: what macrophage autophagy reveals about atherosclerosis |
| Q64885927 | Shen-Yuan-Dan Capsule Attenuates Atherosclerosis and Foam Cell Formation by Enhancing Autophagy and Inhibiting the PI3K/Akt/mTORC1 Signaling Pathway. |
| Q37428190 | Silymarin attenuates cigarette smoke extract-induced inflammation via simultaneous inhibition of autophagy and ERK/p38 MAPK pathway in human bronchial epithelial cells |
| Q93103980 | Subclinical atherosclerosis and its progression are modulated by PLIN2 through a feed-forward loop between LXR and autophagy |
| Q37603471 | Systemic application of 3-methyladenine markedly inhibited atherosclerotic lesion in ApoE-/- mice by modulating autophagy, foam cell formation and immune-negative molecules. |
| Q39155198 | Target acquired: Selective autophagy in cardiometabolic disease |
| Q34992642 | Targeting annexin A7 by a small molecule suppressed the activity of phosphatidylcholine-specific phospholipase C in vascular endothelial cells and inhibited atherosclerosis in apolipoprotein E⁻/⁻mice |
| Q91276580 | Targeting mitochondria for cardiovascular disorders: therapeutic potential and obstacles |
| Q37718232 | Tet methylcytosine dioxygenase 2 inhibits atherosclerosis via upregulation of autophagy in ApoE-/- mice |
| Q42534041 | The Cannabinoid Receptor 2 Protects Against Alcoholic Liver Disease Via a Macrophage Autophagy-Dependent Pathway |
| Q95266071 | The Effect of Shen-Yuan-Dan Capsule on Autophagy-Related Gene Atg13 Promoter Methylation and Genomic Methylation Levels in Atherosclerotic Mice |
| Q64118773 | The Potential Role of the NLRP3 Inflammasome Activation as a Link Between Mitochondria ROS Generation and Neuroinflammation in Postoperative Cognitive Dysfunction |
| Q37723252 | The Role of Macrophage Lipophagy in Reverse Cholesterol Transport |
| Q91595744 | The clearance of dead cells by efferocytosis |
| Q27026138 | The cooperation between the autophagy machinery and the inflammasome to implement an appropriate innate immune response: do they regulate each other? |
| Q47106428 | The crystal-induced activation of NLRP3 inflammasomes in atherosclerosis |
| Q59339809 | The physiology of foamy phagocytes in multiple sclerosis |
| Q47883462 | The protease inhibitor E64d improves ox-LDL-induced endothelial dysfunction in human aortic endothelial cells |
| Q37423513 | The protective role of Sirt1 in vascular tissue: its relationship to vascular aging and atherosclerosis |
| Q99603394 | The role of autophagy in abdominal aortic aneurysm: protective but dysfunctional |
| Q35037113 | The role of autophagy in vascular biology |
| Q28085161 | The role of oxidative stress and autophagy in atherosclerosis |
| Q26770018 | The roles of macrophage autophagy in atherosclerosis |
| Q39109119 | The walking dead: macrophage inflammation and death in atherosclerosis. |
| Q36930186 | Ursolic acid enhances macrophage autophagy and attenuates atherogenesis |
| Q54499199 | Wip1-Dependent Regulation of Autophagy, Obesity, and Atherosclerosis |
| Q24304996 | XBP1 mRNA splicing triggers an autophagic response in endothelial cells through BECLIN-1 transcriptional activation |
| Q33809004 | miR-155 Promotes ox-LDL-Induced Autophagy in Human Umbilical Vein Endothelial Cells. |
| Q38827780 | microRNA-33 Regulates Macrophage Autophagy in Atherosclerosis |
Search more.